RNS Number : 0828M
Deepverge PLC
18 January 2021

AIM share code: DVRG

18 January 2021

DeepVerge PLC

("DeepVerge" or "Company")



Exercise of Options


DeepVerge announces that it has received notification from UK EMI employee share option holders to exercise 25,860 shares in the issued share capital of DeepVerge ("the Option Shares"). The consideration for the exercise of the Option Shares at nominal value of 0.1p amounts, in aggregate, to a cash value of £25.86.


Application will be made for the Option Shares to be admitted to trading on AIM ("Admission"). Admission is expected to be on or about 22 January 2021.


Total voting rights


The Company's total issued capital, after the issue of the Option Shares, will be 169,540,071 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.





DeepVerge plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050



About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.